Page last updated: 2024-12-05

3,5-xylenol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

3,5-xylenol: RN given refers to 3,5-isomer [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

3,5-xylenol : A member of the class of phenols that phenol substituted by methyl groups at positions 3 and 5. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID7948
CHEMBL ID191740
CHEBI ID38572
SCHEMBL ID28714
MeSH IDM0067071

Synonyms (75)

Synonym
AC-7353
1,3,5-xylenol
sym-m-xylenol
CHEBI:38572 ,
1,5-dimethyl-3-hyperoxybenzene
inchi=1/c8h10o/c1-6-3-7(2)5-8(9)4-6/h3-5,9h,1-2h
nsc-9268
wln: qr c1 e1
nsc9268
108-68-9
1-hydroxy-3,5-dimethylbenzene
3,5-dimethylphenol
3,5-dmp
3,5-xylenol
phenol, 3,5-dimethyl-
NCGC00091574-01
3,5-dimethyl phenol
hsdb 5385
ai3-01553
ccris 724
nsc 9268
xylenol 200
einecs 203-606-5
benzene, 1,3-dimethyl-5-hydroxy-
3,5-dimethylphenol, analytical standard
3,5-dimethylphenol, >=99%
D0778
CHEMBL191740
3,5-dimethyl-phenol
D1829
AKOS000119350
NCGC00091574-02
NCGC00257396-01
dtxcid105148
cas-108-68-9
dtxsid1025148 ,
tox21_303372
NCGC00259730-01
tox21_202181
sym.-m-xylenol
5-hydroxy-m-xylene
ec 203-606-5
ona760g0wa ,
unii-ona760g0wa
FT-0614698
ERH ,
3,5-dimethylphenol-2,4,6-d3
3,5-dimethylphenol [hsdb]
metacresol impurity j [ep impurity]
xylenol 3,5-dimethylphenol
xylenol 3,5-dimethylphenol [mi]
xylenol, 3,5-
3,5-dimethylphenol [usp impurity]
3.5-dimethylphenol
3, 5-dimethylphenol
SCHEMBL28714
Q-200352
1,5-dimethyl-3-hydroxybenzene
3,5-xylen-1-ol
1,3-dimethyl-5-hydroxybenzene
3,5-dimethylphenol-d10
1192812-51-3
F0001-0176
mfcd00002307
3,5-dimethylphenol, pestanal(r), analytical standard
3,5-dimethylphenol, 98%
3,5-dimethylphenol 100 microg/ml in methanol
Q26841188
AS-13592
AMY12552
EN300-20196
STL194292
D89931
3,5-dimethylphenol(1,3,5-xylenol)
Z104477220

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Our results show that cresols are more toxic than phenol, that xylenols do not exhibit significantly higher toxicity than cresols, and that trimethylphenols are less toxic than cresols."( Acute toxicity of cresols, xylenols, and trimethylphenols to Daphnia magna Straus 1820.
Devillers, J, 1988
)
0.27
" The cresols were 5-fold more toxic than phenol, whereas 2-ethylphenol and 3,4-xylenol were 11-fold more toxic, and 2,5-xylenol was 34-fold more toxic than phenol."( Toxicity and kinetic parameters of the aerobic biodegradation of the phenol and alkylphenols by a mixed culture.
Acuña-Argüelles, ME; Olguin-Lora, P; Razo-Flores, E, 2003
)
0.32
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
xenobiotic metaboliteAny metabolite produced by metabolism of a xenobiotic compound.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
phenolsOrganic aromatic compounds having one or more hydroxy groups attached to a benzene or other arene ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
2,5-xylenol and 3,5-xylenol degradation427

Protein Targets (11)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
RAR-related orphan receptor gammaMus musculus (house mouse)Potency36.53280.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency2.99960.000714.592883.7951AID1259369; AID1259392
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency12.22200.013326.981070.7614AID1346978
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency39.81070.011212.4002100.0000AID1030
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency21.37410.003041.611522,387.1992AID1159552; AID1159553
estrogen nuclear receptor alphaHomo sapiens (human)Potency12.66480.000229.305416,493.5996AID743069
peroxisome proliferator-activated receptor deltaHomo sapiens (human)Potency63.47450.001024.504861.6448AID743215
caspase-3Homo sapiens (human)Potency12.22200.013326.981070.7614AID1346978
Caspase-7Cricetulus griseus (Chinese hamster)Potency1.22220.006723.496068.5896AID1346980
caspase-3Cricetulus griseus (Chinese hamster)Potency1.22220.006723.496068.5896AID1346980
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency68.72910.000323.4451159.6830AID743065
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (2)

Assay IDTitleYearJournalArticle
AID1149269Antimicrobial activity against Aspergillus niger1976Journal of medicinal chemistry, May, Volume: 19, Issue:5
Quantitative structure-activity relationships. 2. A mixed approach, based on Hansch and Free-Wilson Analysis.
AID237685Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (54)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (40.74)18.7374
1990's10 (18.52)18.2507
2000's11 (20.37)29.6817
2010's7 (12.96)24.3611
2020's4 (7.41)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 39.76

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index39.76 (24.57)
Research Supply Index4.03 (2.92)
Research Growth Index4.53 (4.65)
Search Engine Demand Index55.42 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (39.76)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.82%)6.00%
Case Studies1 (1.82%)4.05%
Observational0 (0.00%)0.25%
Other53 (96.36%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]